+91 8929665177
011-41013054
info@labassure.com
Home
Genetics Diagnostics
Pregnancy
Maternal / Prenatal Screening
Pre-eclampsia Screening and Diagnosis
Prenatal Diagnosis
Non Invasive Prenatal Screening (NIPS)
Infertility
Chromosomal Studies
Recurrent Miscarriage
Pre-implantation Genetic Screening (PGS)
Children’s Disorders
Cancer
Infectious Disorders
Covid 19 Testing
Tests
Constitutional (Paediatric & Prenatal)
Cancer – Test List
Technologies
Karyotyping
FISH
Chromosomal Microarray Analysis
Whole Exome Sequencing
Fully Automated Immunoanlyzer – B•R•A•H•M•S KRYPTOR
About Us
Promoters
Advisers
Downloads
Events
Research
White Papers
Publications
Knowledge
Training
Blog
Contact Us
Pregnancy
Children’s Disorders
Recurrent Miscarriage
Cancer
Maternal / Prenatal Screening
Welcome to Blog
Filter by
Categories
Tags
Authors
Show all
All
AGILE
Genetics
Microarray
Pediatric
POC
Postnatal
Pregnancy
Prenatal
Prenatal Screening
Sequencing
Uncategorized
All
ACOG and SMFM endorse Chromosomal Microarray Analysis
Affymetrix CytoScan Optima Chip
Blog - AGILE
CES
Chromosomal abnormalities
chromosome
Clinical Exome
CMA
CMA in Detection of Prenatal Chromosome Abnormalities
CMA in Fetus with Ultrasound Anomalies
COMPARISON-OF-MICROARRAYS
Demystifying Miscarriages
DNA Testing
Downs Syndrome
Genetic Diagnosis
Genetic Lab
How risky are invasive procedures?
ISO 15180
ISO 15189
Karyotype
Maternal Screening
medical laboratories
microarray
Microarray recommendations
Microarrays
New Technologies in Prenatal Genetic Diagnosis
Next Generation Sequencing
NGS
nipt
POC
Postnatal
Prenatal
Prenatal Diagnosis
Prenatal Diagnosis Using Microarrays
Prenatal Screening
products of conception
Talk on Beyond Karyotype
TURNER SYNDROME
WES
Whole Exome Sequencing
All
superhardy
April 13, 2017
NABL Certification
Our experience of implementing ISO 15189 (NABL Certification) Sharing some insights and learning from our experience of implementing the ISO 15180 standard for medical laboratories
[…]
